| Jean E Talbert, MD | |
|
182 Palmer Ave, Falmouth, MA 02540 | |
| (508) 457-0088 | |
| (508) 540-9613 |
| Full Name | Jean E Talbert |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 182 Palmer Ave, Falmouth, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407918741 | NPI | - | NPPES |
| 3078965 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 73950 (Massachusetts) | Primary |
| Entity Name | Upmc Western Maryland Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184769952 PECOS PAC ID: 7113900655 Enrollment ID: O20040608000157 |
News Archive
A recent Washington Post editorial "wrongly criticized" Sen. Tom Coburn (R-Okla.) and "his colleagues for conducting due diligence" regarding legislation to reauthorize the President's Emergency Plan for AIDS Relief, Sen. Judd Gregg (N.H.), ranking Republican on the Senate Budget Committee's Appropriations Subcommittee on State and Foreign Operations, writes in a Post letter to the editor (Gregg, Washington Post, 6/5).
Viventia Biotech has announced results of in vitro cytotoxicity and in vivo pharmacokinetic studies conducted to evaluate the potential for combining its phase III anti-cancer antibody therapeutic, Proxinium, with first-line standard of care therapy for squamous cell carcinoma of the head & neck (SCCHN).
Æterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with advanced or recurrent endometrial cancer.
According to a new study, the status of lymph nodes rather than the status of the primary tumor following preoperative neoadjuvant chemotherapy or chemoradiation therapy is the most important factor that determines whether patients with locally advanced esophageal cancer will survive.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jean E Talbert, MD 182 Palmer Ave, Falmouth, MA 02540 Ph: (508) 457-0088 | Jean E Talbert, MD 182 Palmer Ave, Falmouth, MA 02540 Ph: (508) 457-0088 |
News Archive
A recent Washington Post editorial "wrongly criticized" Sen. Tom Coburn (R-Okla.) and "his colleagues for conducting due diligence" regarding legislation to reauthorize the President's Emergency Plan for AIDS Relief, Sen. Judd Gregg (N.H.), ranking Republican on the Senate Budget Committee's Appropriations Subcommittee on State and Foreign Operations, writes in a Post letter to the editor (Gregg, Washington Post, 6/5).
Viventia Biotech has announced results of in vitro cytotoxicity and in vivo pharmacokinetic studies conducted to evaluate the potential for combining its phase III anti-cancer antibody therapeutic, Proxinium, with first-line standard of care therapy for squamous cell carcinoma of the head & neck (SCCHN).
Æterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with advanced or recurrent endometrial cancer.
According to a new study, the status of lymph nodes rather than the status of the primary tumor following preoperative neoadjuvant chemotherapy or chemoradiation therapy is the most important factor that determines whether patients with locally advanced esophageal cancer will survive.
› Verified 8 days ago
Bernard Michael Nagel Jr., MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 90 Ter Heun Dr, Second Floor, Falmouth, MA 02540 Phone: 508-457-0088 Fax: 508-540-9613 | |
Richard Abisla, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 210 Jones Rd, Falmouth, MA 02540 Phone: 508-457-1500 | |
Mr. Paul E Demeo, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 182 Palmer Ave, Falmouth, MA 02540 Phone: 508-457-0088 Fax: 508-540-9613 | |
Susan Anderegg, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Cape Obs. Midwifery/gyn., 182 Palmer Avenue, Falmouth, MA 02540 Phone: 508-457-0088 | |
Dr. Holly Zheng, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 Ter Heun Dr, Falmouth, MA 02540 Phone: 508-457-0088 Fax: 508-540-9613 | |
Elizabeth G Murray, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 182 Palmer Ave, Falmouth, MA 02540 Phone: 508-457-0088 Fax: 508-540-9613 |